‘Treating Naturally Occurring Disease’, explained by Founder, Professor Noel Fitzpatrick

Humanimal Trust advocates for studying naturally occurring diseases in animals to advance cancer and osteoarthritis treatments for both humans and animals.

Pharmalittle: We’re reading about a CEO change at AbbVie, a long-acting HIV drug, and more

Rise and shine, everyone. The middle of the week is upon us. Have heart, though. You made it this far, so why not hang on

February 21, 2024

Genmab receives EC approval for lymphoma therapy

TEPKINLY has been approved as a monotherapy to treat adults with relapsed or refractory diffuse large B-cell lymphoma. Credit: Komsan Loonprom/Shutterstock.com. Genmab has received conditional

September 26, 2023

Treating Kids’ HCV Early May Boost Lifetime Health Outcomes and Save Money

Treating hepatitis C virus (HCV) earlier in kids was associated with better lifetime clinical outcomes and lower healthcare costs compared with deferring treatment, a modeling

March 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.